Dianalitics
Donnelley Financial Solutions
DFIN · v1 · 2026-10-05
hourglass
Loading…
Preparing the latest DD data, styles and content.
66OpportunityDD: Oct 05, 2026Analyst: 66
paidPrice at analysis date
USD 46.6 (05/10/2026)
domainMkt cap
$1.64B
pie_chartShares
24.6M
candlestick_chart52W
$36.11-$56.26
trending_downShort interest
4.5%
INFONYSEInformation Technology1900 employees
Verdict: Moderately Attractive

Mispriced compliance-tech transition: Software now 44% of revenue growing +7.8% YoY, ActiveDisclosure +29% YoY (4th consecutive 20%+ quarter), record Q2 EBITDA margin 36.7% (+170bps). Forward P/E 8.7x is clear discount to compliance-tech peers (SSNC 15x, BR 26x). Aggressive buyback (~10% share reduction/year) compounds per-share FCF. Capped by secular print decline (-15% Q2) and SEC Reg E-Delivery proposal that could further compress print by 2028. Base-case +23% upside; this is a VALUE play on buyback compounding, not a growth re-rate.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-10-05
66
Donnelley Financial Solutions (DFIN)
Compliance SaaS + Capital Markets Services · NYSE · Chicago, IL
"Software mix shift accelerating, buyback compounding; valuation discount persists on print-exposure optics"
Fwd P/E 8.7x Q2 EBITDA mg 36.7% ActiveDisclosure +29% FCF yield ~9.4% Print –15% secular
Fin. strength
15
/20 pts
EBITDA/FCF
12
/15 pts
Debt/leverage
11
/15 pts
Stage/business
9
/15 pts
Catalysts
5
/10 pts
Reg. risk
5
/8 pts
Risk/reward
5
/7 pts
Management
3
/5 pts
Sector/macro
1
/3 pts
Compliance
2
/2 pts
💡 Fair Value estimate — Forward P/E peer multiple with FCF yield cross-check
Fair value base case
USD 57.4
Range: USD 47.0-USD 69.0
Price at analysis date: USD 46.6 (05/10/2026)
Base upside/downside: +23%

Primary = forward P/E with peer-derived multiple (compliance-tech median 15x, adjusted −3.4x net for growth/print exposure, uplift for buyback). Cross-checks = EV/EBITDA ($59) and FCF yield ($68). Scenario-weighted FV = 0.25×$69 + 0.50×$57.5 + 0.25×$35 = $54.75 (−5% vs base case but still +18% vs spot). Factor overlay for VALUE: scenario weights centered on base (50%) to reflect yield-of-earnings mindset; bull/bear symmetric at 25/25 given discount already priced in. Sensitivity: a 1x move in applied P/E = ±$4.95 (±8.6% of base FV). ⚠️ Not investment advice.

ComponentAssumptionUSD/share
Peer-median forward P/ECompliance-tech median = 15.0x (SSNC 15x, BR 26x, DNB 10x, FDS 24x, Virtus 10x; trimmed mean of inner four)15.0x
Growth / scale discountDFIN revenue growth 2–3% vs peer 8–12%; subscale vs BR/FDS → −20% multiple haircut−3.0x
Print-exposure discountPrint still ~12% of revenue, declining 15%/yr; SEC Reg E-Delivery long tail → −10% further haircut−1.2x
Buyback / capital-return uplift~10% share-count reduction/yr vs peer ~2% → +0.8x premium (per-share compounding)+0.8x
Applied forward P/E15.0 − 3.0 − 1.2 + 0.8 = 11.6x applied to forward EPS 2026E11.6x
Forward EPS 2026EQ2 adj EPS $1.76 × ~2.8x annualization (Q3 seasonal low, Q4 proxy strong); mid-point $4.95$4.95
FV base case11.6x × $4.95 = $57.42≈ $57.40
Bull
$67.00–$71.00
Probability: 25%
Capital markets activity (IPOs/M&A) remains robust through 2027; ActiveDisclosure growth stays above 20%; software mix passes 50%; multiple re-rates to 13.5x fwd EPS ($5.20); analyst targets of $70 hit.
Base
$55.00–$60.00
Probability: 50%
Software grows 7–9%, print declines 10–15%, overall revenue flat to +3%; EBITDA margin 35–36%; buyback retires 9–10% of shares; multiple holds at 11–12x fwd EPS; dividend-free total return 20–25%.
Bear
$32.00–$38.00
Probability: 25%
Capital markets freeze: transactional revenue drops 25–30%; Workiva displaces ActiveDisclosure at mid-market; print accelerates toward Reg E-Delivery; EBITDA margin falls to 28%; multiple compresses to 7x fwd EPS ~$4.70 = $33.
Methodology: Primary = forward P/E with peer-derived multiple (compliance-tech median 15x, adjusted −3.4x net for growth/print exposure, uplift for buyback). Cross-checks = EV/EBITDA ($59) and FCF yield ($68). Scenario-weighted FV = 0.25×$69 + 0.50×$57.5 + 0.25×$35 = $54.75 (−5% vs base case but still +18% vs spot). Factor overlay for VALUE: scenario weights centered on base (50%) to reflect yield-of-earnings mindset; bull/bear symmetric at 25/25 given discount already priced in. Sensitivity: a 1x move in applied P/E = ±$4.95 (±8.6% of base FV). ⚠️ Not investment advice. Not investment advice.
⚠️ Methodology note: Trailing P/E of 31.9x is distorted by 2025 one-off charges that compressed GAAP net income to $32.4M vs $92.4M in 2024. The relevant earnings proxy is forward adjusted EPS (consensus ~$5.33) and FCF (TTM $107.8M). Fair value anchored on forward P/E and EV/EBITDA, cross-checked with FCF yield. Peer set is tech-enabled compliance/financial-services software (not generic business services).
📊 Capital Structure · Short Interest · Buyback & Dilution
🟡 Short Interest
~4.5%
~1.1M shares shorted on 24.6M outstanding. Days to cover ~5. Modest; typical of small-cap services with sector-rotation uncertainty. No short-squeeze setup; no capitulation signal.
🟢 Share buyback (TTM)
~$110M
Q2 2026 repurchased 763,000 sh for $34.7M; Q1 ~$24.6M; $125.4M remaining on authorization. Share count down from 27.2M to 24.6M (−9.7% in 12 months). Buyback yield 9.7% — among highest in US small-cap services.
🟢 Dilution risk
Minimal
No ATM, no equity raises planned; SBC <$10M/yr fully offset by buyback. Net share count reduction will continue 2026–2027 at $100–120M/yr pace unless balance sheet is redirected (M&A).
Short Interest — context
DFIN — 4.5%
4.5%

Short interest sits in the 4–5% range, consistent with a small-cap business-services name without a thematic short case. The main concerns driving shorts are print secular decline and limited top-line growth — both already fully reflected in the forward P/E of 8.7x. No crowded-short dynamic. Buyback consumes ~20% of average daily volume, providing structural support.

$Financial analysis — FY 2026
Revenue (TTM)
$777.5M
+3.0% YoY
Adj EBITDA margin (Q2)
36.7%
+170 bps YoY (record)
FCF (TTM)
$107.8M
FCF yield 9.4%
Net Debt / EBITDA
1.28x
$157M net debt on $123M EBITDA
ItemFY2023FY2024FY2025FY2026EGuidance 2027
Revenue ($M)783809767795N/A — not provided
Software Solutions ($M)285320345378N/A
Adj EBITDA ($M)230255230265N/A
Adj EBITDA margin (%)29.431.530.033.3N/A
GAAP net income ($M)88923290N/A
Adj EPS ($)3.203.453.754.95>$5.50 implied
FCF ($M)95108108115N/A
Shares outstanding (M)3027.526.524.0~21.5

FY2025 GAAP net income was depressed by one-off charges (goodwill impairment on legacy print, restructuring). Adj EPS continues upward because share-count reduction compounds. FY2026E assumes revenue +3.6% (software +9.5%, print −12%), EBITDA margin lifting 300bps to 33.3% on software mix, FCF stable at $115M. Guidance only provided quarter-ahead ($175–185M Q3 sales, 26–28% EBITDA margin reflecting Q3 seasonal low).

attach_money

Quarterly trend

PeriodTotal rev ($M)Software ($M)Software %Adj EBITDA mgAdj EPS ($)Shares (M)
Q1 2025190.580.242.1%28.5%0.8429.0
Q2 2025218.192.242.3%35.0%1.6228.4
Q3 2025179.483.546.5%24.5%0.5227.5
Q4 2025179.089.249.8%27.0%0.7727.0
Q1 2026202.693.546.2%31.0%1.2125.4
Q2 2026224.299.444.3%36.7%1.7624.6

Mix is now visibly software-led: software revenue dollars grew from $80M (Q1 2025) to $99M (Q2 2026) — +24% in 5 quarters. Capital-markets transactional revenue in Q2 was +36% YoY ($47M) driven by S-1 IPO activity, with roughly a third of ActiveDisclosure's +29% growth attributable to post-IPO retention of S-1 filers. Share count fell from 29.0M to 24.6M (−15%) over the same window — pure per-share compounding.

account_tree

Business segments & competitive position

Capital Markets — Software $215M · +9% YoY RAMP ActiveDisclosure (SEC filings, iXBRL AI tagging) +29% YoY. Direct competitor to Workiva at mid-market pricing. Venue (deal rooms, M&A dataroom) growing high single-digit. Strongest asset in the portfolio; margins 45%+. Capital Markets — Compliance $295M · flat TRANSITION Transactional printing + filings for IPO, M&A, debt deals. Q2 2026 +36% on cyclical rebound. Benefits from capital-markets activity, exposed to pipeline freeze. Lower-margin (~22%) but high operating leverage. Investment Companies — Software $160M · +6% YoY RAMP Arc Suite — regulatory reporting for 1940-Act funds (N-PORT, N-CEN, Form N-MFP). Required by SEC; locked-in SaaS. Growing with industry consolidation. High-30% margins. Lower growth than ActiveDisclosure but ultra-sticky. Investment Companies — Compliance $80M · −8% YoY DECLINE Printed prospectuses & shareholder reports — the structural loser. SEC Rule 30e-3 already pushed most to e-delivery; proposed Reg E-Delivery would effectively eliminate print by 2028. Managed-decline cash cow. Print & Distribution $30M · −15% YoY RUN-OFF Legacy printing operations outside investment-companies filings. Being downsized actively; capacity reductions improving blended margins as it rolls off. Services / Other $0M · n/a N/A Residual services and advisory revenue; immaterial standalone. Not broken out separately in management reporting.

Competitive moat: Mid-grade. ActiveDisclosure's AI-driven iXBRL tagging is a credible competitor to Workiva for mid-market filers (below Fortune 500). Arc Suite benefits from regulatory lock-in — 1940-Act funds cannot easily switch providers mid-year. Print assets have no moat. Overall, DFIN is transitioning from a declining services business to a mid-tier compliance SaaS platform — the question is whether the SaaS growth outruns the print decline, which the Q2 2026 mix (software 44%+, growing 7.8%) suggests it already does on a run-rate basis.

account_tree

SWOT

Strengths
  • +Software mix now 44% and growing +7.8% — crossed inflection
  • +Record Q2 EBITDA margin 36.7% (+170bps) — operating leverage proven
  • +FCF yield 9.4%, buyback consuming ~10% of shares/yr
  • +ActiveDisclosure +29% YoY 4 consecutive quarters — not a one-off
  • +Regulatory lock-in on Arc Suite for 1940-Act funds
Weaknesses
  • −Total revenue stuck at 2–3% growth — mix is improving, not scale
  • −Print still ~12% of revenue, declining 15%/yr — headline drag
  • −Dependent on capital-markets activity cycles (IPO/M&A)
  • −GAAP EPS volatile (2025 one-offs); ROE depressed at 8.6%
  • −No dividend — relies entirely on buyback for return of capital
Opportunities
  • →AI iXBRL tagging monetization — ActiveDisclosure premium tier
  • →Multiple re-rate if software mix passes 50% in 2027
  • →Share-count reduction compounds EPS even on flat revenue
  • →Potential M&A target for a larger compliance platform (SSNC, BR)
  • →Capital-markets activity remains elevated into 2027 under current admin
Threats
  • !SEC Reg E-Delivery (proposed) eliminates most print by 2028
  • !Workiva (WK) can displace ActiveDisclosure at mid-market
  • !IPO/M&A pipeline freeze (recession) collapses transactional revenue
  • !Software margin compression if AI commoditizes iXBRL tagging
  • !Buyback dependent on continued FCF — margin compression breaks thesis
article

Catalysts (next 12 months)

2026-10-28 Earnings Q3 2026 earnings — guidance mid-point $180M revenue High impact Binary Short-term Q3 is seasonally the weakest quarter (margin 26–28% vs 36% Q2); market will focus on ActiveDisclosure growth continuation and buyback cadence. Guidance for Q4 critical. 2026-Q4 Regulatory SEC Reg E-Delivery final rule timing High impact Bearish Medium-term If finalized with 2028 implementation, overhang on print valuation lifts (bad news priced in); delay to 2029+ gives 1 more year of print profit. Either outcome moderately clarifying. 2027-01 Earnings Q4 2026 + FY27 guidance — mix inflection check High impact Bullish-biased Short-term Full-year 2026 adj EPS likely ~$5 (vs $3.75 FY25) — this is the proof point that justifies multiple re-rate. FY27 guidance will set the base for continued buyback intensity. 2026-Q4 Strategic New CRO Ken Napolitano — sales reorganization Medium impact Bullish Medium-term Appointed Sep 2026 to accelerate ActiveDisclosure cross-sell into existing Arc Suite base and new logo wins. Impact visible 2–3 quarters out. 2027-H1 Product ActiveDisclosure AI premium tier rollout Medium impact Bullish Medium-term AI-driven iXBRL tagging and automated translation are packaged for upsell; could drive ARPU +10–15% in the ActiveDisclosure base of ~500 customers. rolling Capital markets IPO/M&A deal volume trajectory High impact Cycle-linked Short-term Transactional revenue +36% in Q2 on IPO rebound. Sustained issuance into 2027 is the single biggest incremental lever (~$40M upside to EBITDA if volumes hold).

gavel

Risk grid

Secular print decline
Medium
Print still ~12% of revenue, declining 15%/yr. Already fully reflected in valuation. Not a thesis-breaker but a drag on headline growth optics.
SEC Reg E-Delivery (2028)
Medium
Would eliminate most print by 2028. Known risk; approximate 10% revenue, 7% EBITDA impact over 2 years. Softened by ongoing print capacity cuts.
Capital-markets cyclicality
High
Transactional revenue (~$180M/yr) swings with IPO/M&A volumes. Full freeze (2022-type) would cost ~$60M revenue, ~$25M EBITDA, breaking buyback cadence.
Workiva competitive displacement
Medium
WK has 20%+ growth, better brand in large-cap. DFIN wins on price/mid-market and S-1 workflow. 4 consecutive quarters of 20%+ growth suggests holding own.
AI commoditization of iXBRL
Low
Core iXBRL tagging increasingly automated. DFIN is on the right side (bundling AI); risk is pricing power. 2–3 year horizon risk, not immediate.
Balance sheet / leverage
Low
Net debt 1.28x EBITDA, $125M buyback authorization remaining. No refinancing wall. FCF covers all capital returns 1.5x. Pristine balance sheet.
Management execution
Low
CEO Dan Leib has run the transition since 2016 spin; delivered 4 consecutive quarters of >20% ActiveDisclosure growth. New CRO strengthens go-to-market. Record margin Q2 2026 confirms execution.
M&A/strategic optionality
Positive
Pure-play compliance platform at <$1.2B mkt cap is an attractive bolt-on for SSNC, BR, or private equity. Not base case but non-trivial upside optionality.
public

Factor summary (why VALUE)

✓ Value traits
  • Fwd P/E 8.7x vs peer median 15x (compliance-tech)
  • EV/EBITDA 8.4x vs peer 10–11x
  • FCF yield 9.4% vs peer 5–6%
  • Buyback yield 9.7% — among highest small-cap
  • Q2 EPS beat 7.98% ($1.76 vs $1.63)
◧ Quality overlay
  • Q2 EBITDA margin 36.7% record
  • ROE depressed 8.6% on 2025 one-offs
  • Net debt/EBITDA 1.28x healthy
  • Software 44% of mix, growing +7.8%
  • FCF conversion ~110% of GAAP NI
✗ Momentum (weak)
  • Stock −11.6% 1-year, YTD −0.3%
  • 52W $36.11–$56.26, trading mid-range
  • Below 200-DMA briefly after Q2 beat
  • Low analyst coverage (3 analysts)
  • No index-ETF buying flow

Verdict on factor classification: DFIN clears VALUE criteria cleanly — forward P/E 8.7x (< 15 threshold) and recent Q2 EPS beat of 7.98% (> 5% threshold). QUALITY is mixed: margins and leverage are excellent, but ROE depressed by one-offs. MOMENTUM is actively weak and that is the opportunity — the stock has been punished for print exposure while the business has been quietly transitioning. The VALUE label is the right lens.

public

Price vs 52-week range

52W low $36.11
$46.56 (now)

Trading 29% off 52W high ($56.26) and 29% above 52W low ($36.11). The sell-off from the summer high is NOT fundamentals-driven — Q2 2026 was a record EBITDA quarter. The derate is sector rotation (small-cap services into higher-growth names). Opportunity for VALUE buyer.

article

⚡ Hidden catalysts block (internal use)

Q3 2026 earnings 2026-10-28 — Q3 is seasonal low; focus is on ActiveDisclosure cadence Potential take-private by PE in 2027 if public multiple remains below 10x fwd EPS SEC Reg E-Delivery finalization — timing uncertain, overhang clears either way Capital markets issuance 2027 — base = normal, upside = continued elevated IPO volumes Buyback authorization refresh expected in Q1 2027 (current $125M remaining will deplete ~Q4 2026) M&A rumor: SSNC, BR, Thomson Reuters are the three logical acquirers at a 25–40% premium

public

Investor profile fit

Who should own DFIN
Value investors who are comfortable with low-growth total-return math: 3% revenue growth + 10% share-count reduction + 2% margin expansion = ~15% intrinsic value compounding, available at an 8.7x forward multiple. No dividend, so unsuitable for income-only portfolios. Appropriate size: 1–3% of a diversified small-cap value sleeve. Catalyst to monitor is NOT top-line growth (will stay low) but share-count trajectory and ActiveDisclosure growth rate. Buyback cadence IS the thesis.
Who should NOT own DFIN
Growth investors needing >10% revenue growth — DFIN will not deliver this. Income investors — no dividend. Thematic AI investors — this is a boring buyback story, not an AI story (even though ActiveDisclosure embeds AI). Short-horizon traders — the thesis plays out across 4–8 quarters of buyback compounding, not days.
Sources & Disclaimer

Report metadata. Factor: VALUE (per screening criteria: forward P/E < 15 + Q2 2026 EPS beat > 5%). Market data — last verified close 2026-10-02 (T-1 trading days vs 2026-10-05 report date). Current price $46.56 confirmed by Yahoo Finance and StockAnalysis.com. Peer multiples sourced from StockAnalysis.com Oct 2026. Fundamental figures sourced from DFIN Q2 2026 earnings call (2026-07-30), Simply Wall St, StockStory, Fool.com transcripts, Tipranks. The 2025 vs 2024 GAAP net income gap reflects one-off goodwill & restructuring charges on legacy print segments — adjusted EPS trajectory remains positive. All forward estimates are the author's modeled consensus, not official company guidance beyond Q3 2026 revenue of $175–185M. Not investment advice. For analytical use only.

Prezzo usato: $46.56 (close 2026-10-02, T-1) — fonti: Yahoo Finance ( finance.yahoo.com/quote/DFIN ), StockAnalysis.com ( stockanalysis.com/stocks/dfin ).